Alcon AG vs Hims and Hers Health Inc — how do they compare? Alcon AG trades at $72.57 (market cap $36.44B), while Hims and Hers Health Inc trades at $30.75 (market cap $7.12B). The key difference: Alcon AG is far larger — about 5.1× Hims and Hers Health Inc's market cap, and Alcon AG pays a 0.48% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.
| ALC | HIMS | |
|---|---|---|
Market Cap | $36.44B | $7.12B |
Sector | Health | Health |
52-Week High | $90.12 | $62.76 |
52-Week Low | $62.02 | $14.52 |
Enterprise Value | $40.28B | $7.82B |
Dividend Yield | 0.48% | — |
Trailing returns across standard periods
Latest headlines on both assets
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →